Why wait for declining profitability before implementing enhanced contract analytics?

Why wait for declining profitability before implementing enhanced contract analytics?

Often companies don’t seriously perform some sort of “analytics” to determine if the signed contract makes financial sense until after they see their margins and profitability declining.  Traditional thinking says as long as rebates paid are more than compensated by increased volume then there is a good deal in place. There is much more to […]

Read More

340B Drug Pricing Program Ceiling Price and Manufacturer Civil Monetary Penalties Regulation

The latest rule coming out from HHS on the 340B Program was published in the Federal Register on January 5, 2017 (Vol. 82, No. 3) and will have the effect of adding workload and compliance risk to your participation in the 340B program.  On January 30, the Trump Administration withdrew this regulation as part of […]

Read More
Top
Menu